In the current studies, we report that immunocompetent lymphoid cells from allogeneic donor guinea pigs stimulate a considerable synthesis of anti-D N P and anti-OVA antibodies by recipients previously primed with DNP-OVA, in the absence of any further antigenic challenge, eliciting thereby a nonspecific anamnestic response. In addition, the transfer of such allogeneic cells prepares DNP-OVA-primed recipients, when challenged at a suitable time, for a second-1 Abbreviations used in this paper: ABC, antigen-binding capacity; BGG, bovine gamma globulin; CFA, complete Freund's adjuvant; DNP-OVA, dinitrophenyl-ovalbumin; GPGG, guinea pig gamma globulin; L~C, transplantable leukemia cells of strain 2 guinea pigs; PBS, phosphate-buffered saline. 169
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ary anti-DNP response to I)NP-BGG; this occurs in an equal degree whether or not the cells are derived from BGG-primed donors. Thus, the activity of nonspecific allogeneic immunocompetent cells (allogeneic effect) replaces very adequately the contribution of carrier-specific syngeneic cells in the stimulation of anti-hapten antibody synthesis and obviates the need for carrier specificity in anti-hapten secondary responses.
On the basis of the failure of irradiated strain 2 guinea pig lymphoid cells, of strain 2 leukemia cells, and of lymphoid cells from (2 X 13) F1 hybrids to mediate this effect in strain 13 guinea pig recipients, it appears that the effect of allogeneic cells is related to a graft-versus-host response. The analysis of the phenomena described in this study may further our understanding of the requirements for stimulation of precursors of antibody-forming cells, and of the mechanism of cooperation between distinct classes of lymphoid cells in antibody responses.
Materials and Methods
In general, the proteins and other reagents used here are identical with those described in the first paper of this series (4) . The following DNP conjugates were employed: I)NPT-OVA, I)NPm-BGG, and DNP~-BGG. Subscripts refer to the average number of moles of I)NP/ mole of protein.
Immunizations.--Adult inbred strain 2 and strain 13 guinea pigs weighing 250-400 g were obtained from the Animal Production Section, National Institutes of Health, Bethesda, Md. Primary immunization of recipients was carried out with 1.0 mg of I)NPT-OVA in saline, intraperitoneally, on 3 successive days. Cell donors were immunized in the footpads with 50/zg of BGG emulsified in complete Freund's adjuvant (CFA, Difco Laboratories, Detroit, Mich.) or with saline emulsified in CFA. 1.0 mg of I)NP-B GG in saline was used for secondary challenge of recipient guinea pigs. This was administered as a 200 #g intradermal dose followed 4 hr later by an 800 /zg intraperitoneal dose. In the case of strain 13 recipients, dlphenhydramine hydrochloride (Benadryl, Parke, Davis & Co., Detroit, Mich.), 5.0 mg/kg, was administered intramuscularly 1 hr before the intraperitoneal dose of DNP-BGG as a prophylactic measure against anaphylaxis. Animals were bled just before the secondary challenge and 4, 7, and 11 days later; antibody determinations were performed as described below.
Antibody Measurements.-Measurement of anti-DNP antibodies:
Serum anti-DNP antibody levels were determined by a modified Farr assay (11) using 3H-i)NP-epsilon-amino-/V-caproic acid (12) . Using standard curves constructed as described previously (4), percentage of binding was converted into amount of anti-i)NP antibody in micrograms per milliliter.
Measurement of anti-BGG antibodies:
Quantitative determination of precipitating anti-B GG antibody was performed with 125I-BGG (4). In this assay, the antigen concentration at which 50% of added antigen (0.1 ml) was precipitated by 0.2 ml of serum was determined (]?5o). P50 is expressed as micrograms of BGG added per milliliter of antiserum.
Measurement of anti-OVA antibodies: Serum anti-OVA antibody levels were determined by the Farr technique (11) using 125I-OVA. Antigen-binding capacities (ABC-33) were determined on the basis of the serum dilution required to bind 33% of a sample of 125I-OVA (6 /zg/ml).
Measurement of Total Serum Gamma Globulin.-
Total serum gamma globulin concentration was determined by quantitative precipitin analysis in the following manner: 50 #1 of rabbit anti-guinea pig gamma globulin (GPGG) (4.85 mg/ml, kindly provided by Dr. Joseph Davie) was reacted with 5-100 #g of GPGG in 50 #1. Reaction mixtures were incubated at 37°C for 1 hr and then held at 4°C for 24 hr. Washed specific precipitates were dissolved in 0.02 ~ sodium lauryl sulfate and absorbancies at 278 m/z were determined. A standard curve was constructed plotting absorbancy against amount of antigen added. This curve was log linear in the range between 5 and 30 #g of added GPGG and was quite reproducible from assay to assay. Antisera to be analyzed for total gamma globulin concentration were diluted 1: 40-1: 80 with PBS. Utilizing the standard curve, the amount of gamma globulin precipitated by both serum dilutions was calculated. These values were then converted to milligrams of gamma globulin per milliliter of serum. Both of the dilutions chosen fell within the log-linear portion of the standard curve in almost every case. Calculated serum concentrations based upon the two dilutions agreed very closely and the mean value is presented.
Cell Transfers.-Donor guinea pigs were immunized in the footpads with either saline in CFA (CFA cells) or with 50/zg of BGG emulsified in CFA (BGG cells). 3 wk later, the animals were sacrificed and axiUary, occipital, inguinal, and popliteal lymph nodes and spleens were removed. Single cell suspensions in Eagle's minimum essential medium were prepared and washed. In each experiment, cell suspensions from BGG cell donors and CFA cell donors were pooled separately. Varying numbers of nucleated cells were transferred intravenously to recipient guinea pigs which had been immunized 3 wk earlier with DNP~-OVA as described above.
Irradiation of Calls.-
Single cell suspensions received a total of 3000 R from two opposing 250 kvp Westinghouse X-ray tubes 25 cm apart. Each had inherent filtration of 0.25 mm Cu + 0.55 mm A1. (halflayer value = 0.91 mm Cu). They were operated at 200 kvp, 15 ma, and gave a combined dose rate of 674 R/rain to cells midway between the tubes.
Statistical Analyses.-
Serum antibody values were logarithmically transformed and means and standard errors calculated. Results from groups were compared by Student's t test.
RESULTS

Stimulation of Antibody Production as a Result of Transfer of Immunocompetent Strain 2 Cells into _Primed Strain 13 Recipients (Allogeneic Effect).--
In the absence of secondary antigen challenge: The transfer of 200 X l0 s lymph node and spleen cells from strain 2 guinea pigs, which had been immunized 3 wk before with either BGG in CFA or CFA only, into DNP-OVA-primed strain 13 recipients resulted in the production of considerable amounts of anti-DNP and anti-OVA antibodies, although no challenge with DNP-conjugate was administered. As shown in Fig. 1 , a very sharp increase in serum anti-DNP antibody concentration occurred between 6 and 10 days after the transfer of allogeneic cells. The peak concentration was noted on day 13, and by day 17 the serum anti-DNP antibody concentration had diminished. The mean magnitude of this increase was 154.0 #g/ml in guinea pigs whose mean serum anti-DNP antibody concentration was 19.4 #g/ml immediately after cell transfer. A comparable rise was noted in anti-OVA antibodies in these recipients. By contrast, the increase in total gamma globulin concentration was only 1.6 mg/ml from an initial mean value of 6.2 mg/ml. Thus, a marked increase in the ratios of concentrations of anti-DNP and of anti-OVA antibodies to total serum gamma globulins occurred in these recipients. A group of control strain 13 animals which had been primed with DNP-OVA but which had not received any strain 2 lymphoid cells showed no change in anti-DNP antibody concentration during this time.
2°° I
The effect of secondary antigen challenge with a DNP-heterologous carrier: Although the marked rises in serum anti-DNP and anti-OVA antibody concentrations described above occurred without secondary antigenic challenge, such a secondary challenge administered at various times after transfusion of allogeneic cells had a considerable effect on anti-DNP antibody levels. Recipients challenged with 1.0 mg of DNP-BGG 6 days after cell transfer displayed serum anti-DNP antibody concentrations 7 days later (13 days after transfer) which were strikingly higher than those of recipients which were not challenged with antigen (Fig. 2) . Furthermore, contrary to expectations, cells from BGG-primed donors were no more effective than cells from CFA-primed donors in preparing recipients for an anti-DNP response to the secondary challenge with DNP-BGG. Thus, as a result of the transfer of allogeneic cells, a considerable secondary anti-DNP response to DNP-BGG could be obtained in animals primed to DNP-OVA. This allogeneic effect therefore appears to remove the need for the action of BGG-specific carrier cells in the secondary response to DNP-BGG. Thus far, attempts to achieve augmented primary anti-DNP antibody responses to DNP-BGG in animals which have received allogeneic lymphoid cells have failed.
When DNP-OVA-primed strain 13 guinea pigs which had received 200 X 106 lymph node and spleen cells from strain 2 animals were challenged with DNP-BGG soon (1 or 3 days) or later (13 days) after cell transfer, the anti-DNP antibody response was totally different from that of similar guinea pigs chal- lenged at 6 days after cell transfer. Fig. 3 illustrates the results of these studies. In the three panels of this figure, the effects of challenge with DNP-BGG at days 1 and 3, day 6, and day 13, respectively, after cell transfer are compared, using as a reference the anti-DNP serum concentrations in animals not challenged, illustrated also in Fig. 1 .
Animals challenged with DNP-BGG 1 day after transfer have lower serum anti-DNP antibody concentrations than do nonchallenged animals. Indeed, the challenged animals display an initial fall in anti-DNP antibody concentration. The concentration is still below that before challenge at 7 days after challenge, and at 11 days after challenge it is only slightly greater than that before challenge. In those animals challenged 3 days after transfer, there is also an initial fall in serum anti-DNP antibody concentration. There is, however, a relatively rapid recovery so that serum anti-DNP antibody levels are greater than in animals challenged 1 day after transfer, but these levels are still less than those of nonchallenged animals. Challenge with DNP-BGG 6 days after allogeneic cell transfer produced a marked enhancement in serum anti-DNP antibody concentrations, compared to nonchallenged animals as described above. Challenge 13 days after cell transfer failed to cause an augmentation of serum anti-DNP antibody levels.
Thus, a crucial relationship must be maintained between time of antigenic challenge and of allogeneic cell transfer to facilitate stimulation of secondary anti-DNP responses by a DNP-heterologous protein conjugate in recipients of allogeneic cells.
Demonstration of the Allogeneic Effect in Strain 2 Recipients of Strain 13
Cells.--The previous experiments have demonstrated the occurrence of the allogeneic effect when cells of strain 2 origin were transferred to strain 13 recipients. That the phenomenon results from allogeneic differences between cells of donor and host origin and is not related to properties unique to strain 13 recipients was confirmed by the demonstration of the same effect in the reciprocal transfer protocol, i.e., where donor cells were obtained from strain 13 guinea pigs and transferred to strain 2 recipients. Both syngeneic combinations (i.e. strain 13 to strain 13 and strain 2 to strain 2) were included in this study as further controls. The same general protocol as described in the previous experiments was followed. All recipients were boosted with DNP-BGG 6 days after transfer. Bleedings were performed on the day of boosting and 4 and 7 days later.
The results are presented in Table I . Recipients of 200 X l0 s allogeneic BGG or CFA cells (groups A and B, respectively) manifested a striking rise in anti-DNP antibody levels between days 6 and 13 after transfer. The effect could be observed as early as day 10 (4 days after challenge) in contrast to the situation in syngeneic combinations which usually do not manifest a rise in anti-DNP levels until day 13 after transfer of carrier-specific cells. Furthermore, the magnitude of the peak anti-DNP response in the allogeneic transfer system is greater than that obtained in strain 2 recipients of 1000 X 106 syngeneic carrierspecific cells (5) . The responses observed in the strain 13 and strain 2 syngeneic combinations after transfer of 200 X 106 cells from BGG-primed donors are shown in Table I by groups C and D, respectively. The response in both instances is poor by day 13; however, a clear enhancement was observed by day 17 (not shown), although it was not of the magnitude seen in the allogeneic combinations.
TA_BLE I
Elicitation of the Allogeneic Effect in DNP-OVA-Primed Strain 2 Guinea Pigs after Passive Transfer oj" Strain 13 Guinea Pig Lymph Node and Spleen Cells
Group Protocol* Anti-DNP antibody ~g/ml)~ 
Effect of Varying Numbers of Transferred Allogeneic Cells.--The preparation
of DNP-OVA-primed strain 13 animals for a secondary anti-DNP antibody response to DNP-BGG can be achieved by the transfer of relatively small numbers of strain 2 lymph node and spleen cells. Thus, while transfer of 10 X l0 G allogeneic cells failed to prepare for a measurable response 7 days after challenge (13 days after transfer), 50 X 106 cells stimulated a clear increase in anti-DNP antibody concentration at that time (Table II) . Increase of transferred cell numbers to 200 X 106 (4-fold) resulted in a secondary response of approximately 6-fold greater magnitude than had occurred when 50 X 106 cells were transferred. A further 3-fold increment in response was noted after the transfer of 1000 X 106 allogeneic cells.
Effect of Presensitization of Strain 13 Recipients with Strain 2 Cells.--The
participation of living allogeneic cells in at least certain phases of this response is well demonstrated by the fact that DNP-OVA-primed strain 13 recipients which have been preimmunized with the transplantable leukemia L2C, which arose in strain 2 guinea pigs (13), do not exhibit any increase in anti-DNP antibody synthesis after allogeneic strain 2 cell transfer. As part of the experiment described in the preceding section, 20 strain 13 animals were inoculated intraperitoneally with 107 live L~C cells (kindly provided by Doctors Leonard Ellman and Ira Green) 15 days after they had been primed with DNPT-OVA. * 10 )< 106 to 1000 X 106 strain 2 lymph node and spleen cells were transferred to individual strain 13 recipients which had been immunized 3 wk earlier with DNP~-OVA. Sensitized recipients (groups F and G) had received 107 strain 2 leukemia cells intraperitoneally 7 days before cell transfer. All recipients were boosted with DNP-BGG 6 days after transfer.
:~ The data are expressed as geometric means. Boost represents the increase in mean antibody levels from the day of boosting (day 6 after transfer) to 7 days later (day 13). A comparison of the geometric mean anti-DNP serum antibody concentrations on day 13 7 days later either 50 or 200 X 106 strain 2 lymph node and spleen cells were transferred to these recipients and 6 days later they were challenged with DNP-BGG. Neither group demonstrated an increase in serum anti-DNP antibody levels over the next 7 days, which is in marked contrast to similar recipients which had not been previously inoculated with the L2C cells (Table  II) . Thus, presensitization to cells bearing strain-specific histocompatibility antigens 2 abrogates the allogeneic effect.
Strain 2 and Allogeneic Strain 13 Recipients of Strain 2 Lymphoid Cells from BGG-Sensitized Donors.--The magnitude of the allogeneic effect demonstrated
in these studies is considerable. Indeed, the effectiveness of BGG-sensitized strain 2 cells to prepare for a secondary anti-DNP response is strikingly greater in strain 13 recipients than in strain 2 recipients when both groups are challenged with I)NP-BGG 6 days after transfer. Thus, Fig. 4 FIO. 4. Relative response to DNP-BGG challenge of DNP-OVA-primed strain 2 syngeneic and strain 13 allogeneic recipients of strain 2 lymphoid cells from BGG-sensitized donors. 1 X 10 s lymph node and spleen cells from BGG-sensitized strain 2 donors were transferred to strain 2 and strain 13 recipients primed with DNP-OVA 3 wk earlier. All recipients were boosted with DNP-BGG 6 days after transfer. Serum anti-DNP antibody concentrations just before challenge and on days 4 and 7 after challenge are illustrated in the large panel. The far right panel illustrates the serum anti-B GG antibody concentrations just before and 7 days after challenge. The numbers in parentheses refer to the numbers of recipients in the given groups. strain 2 and strain 13 recipients of 1000 X 106 BGG-sensitized strain 2 lymph node and spleen cells to challenge with DNP-BGG. A response in the allogeneic recipients is already apparent on day 4 after challenge; on day 7, the serum anti-DNP concentration is 170-fold greater than it was before challenge. In contrast, the syngeneic (strain 2) recipients do not demonstrate a measurable response 4 days after challenge, and on day 7 the anti-DNP level is 70-fold greater than it was just before challenge. Again, however, in the interpretation of responses in the allogeneic system, the fact that a considerable response occurs without antigen challenge must be taken into account.
Although the anti-DNP response in strain 13 recipients of cells from BGGprimed strain 2 guinea pigs is greater than is the anti-DNP response of strain 2 recipients, the reverse is true of the anti-BGG responses. Anti-BGG antibodies are not detected (P~0 < 5/zg/ml) either before DNP-BGG challenge or 7 days later in the allogeneic recipients, whereas they are measurable before challenge in the syngeneic recipients and their concentration increases 7 days later. This suggests that the allogeneic effect does not require the active participation of immunoglobulin-secreting donor cells, at least at the time of antigenic challenge. by acting as effectors of a graft-versus-host response. In order to choose between these two possibilities, we studied the capacity of irradiated strain 2 lymphoid cells, of strain 2 leukemia cells, and of (2 X 13)F1 hybrid lymphoid cells to mediate the allogeneic effect in DNP-OVA-primed strain 13 recipients. Table III demonstrates that 3000 R administered in vitro completelyabolishes the capacity of lymph node and spleen cells from strain 2 guinea pigs to prepare I)NP-OVA-primed strain 13 recipients for a secondary re-sponse to DNP-BGG. This is of particular interest because the capacity of syngeneic BGG-primed lymphoid cells to prepare for such a response has previously been shown not to be diminished by in vitro irradiation with doses as high as 5000 R (10). The allogeneic and syngeneic transfers appear therefore to utilize separate mechanisms for the stimulation of the recipients' precursors of antibody-forming cells.
TABLE III Capacities of Nonirradiated and Irradiated Lymph Node and Spleen Cells, Leukemia Cells and Normal Spleen Cells from Strain g Guinea Pigs to Elicit the Allogeneie Effect in Strain 13 Recipients
Furthermore, L2C strain 2 leukemia cells fail to prepare DNP-OVA-primed strain 13 guinea pigs for an anti-DNP response to DNP-BGG. These two experiments therefore suggest that immunocompetent, radiation-sensitive cells are required for the expression of the allogeneic effect. In addition, as shown in Table III , 200 X 106 spleen ceils from normal strain 2 donors are inferior to an equal number of lymph node and spleen cells from CFA-primed strain 2 donors in mediating the allogeneic effect. This suggests that a subpopulation of lymphoid cells more numerous in lymph node than in spleen is involved in the response. Table IV presents results from another experiment in which the radiation sensitivity of the allogeneic effect is clearly demonstrated. The data further show that both the response which depends on antigen challenge and the one which is independent of such challenge are equally inhibited as a result of in vitro irradiation of donor lymphocytes.
Finally, in the experiment illustrated by Table IV , transfer of 200 X 106 (2)< 13)F1 hybrid lymph node and spleen ceils from CFA-primed animals failed to prepare DNP-OVA-primed strain 13 recipients for an anti-DNP response to DNP-BGG. Thus, not only must the transferred cells be immunocompetent, they must also have the genetically-determined capacity to respond to the histocompatibility antigens of the recipient. These experiments, taken together, provide strong evidence that the allogeneic effect observed here is mediated through the immunologic attack of graft cells on host cells. It should also be noted that in those cases in which the allogeneic effect was noted, recipients displayed enlarged spleens. The latter is a regular occurrence in graft-versus-host reactions.
DISCUSSION
A considerable body of evidence now exists which demonstrates that two independent lymphoid cell populations participate, in a specific way, in antibody responses. Cell interactions have been described, thus far, in humoral immune responses to foreign erythrocyte antigens (14-16), proteins (17, 18) , and hapten-protein conjugates (4) (5) (6) (7) (8) . In the study of responses to the latter class of antigens, it has become clear that the participating cells may be specific for different determinants on the immunogen and that the two cell types may display a different range of effective specificity (5, 8, 19) .
Of the cell types involved, one appears to be the direct precursor of antibody-forming cells and to possess receptors with specificity identical with that of the antibody to be secreted by its progeny. The other cell fails to secrete detectable amounts of antibody, but nevertheless plays a role in the activation of the precursor described above (3, 20, 21) . In the mouse, this "helper" cell has been demonstrated to be thymus-derived and to bear the isoantigen 0 (8, 22) . The receptors possessed by this cell t~e appear not to recognize many haptenic determinants, or members of this cell type with highly hapten-specific receptors are rare. This involvement of two cell types and their distinct specificity characteristics appears to largely explain the phenomenon of carrier specific- In addition to the spontaneous synthesis of both anti-DNP and anti-OVA antibody in the absence of antigenic challenge, a considerable anti-DNP response ensues to immunization with DNP-BGG. This latter effect in the allogeneic transfer system is, however, rather different from that previously described in syngeneic transfer systems. In the syngeneic transfer, preparation for secondary response is dependent on the specificity of the transferred cells. Cells from BGG-primed donors prepare the recipient for a secondary anti-DNP response to DNP-BGG; cells from CFA-primed donors have no effect (5) . In the allogeneic transfer, cells from BGG-prilned and from CFA-primed donors are equal in efficiency in preparing for a secondary anti-DNP response to DNP-BGG. In the syngeneic system, the effectiveness of carrier-specific donor cells is preserved after in vitro exposure to as much as 5000 R of X-irradiation (10), whereas 3000 R completely prevents allogeneic cells from exerting their effect upon transfer.
These differences point to a distinction in the mechanism by which the transferred cells function in the two situations. It seems most likely that in the syngeneic transfer of cells from BGG-primed donors the transferred cells act in a way similar to the normal, physiologic action of autologous helper cells in the activation of precursors of antibody-forming cells. The establishment of the nature of this action is one of the key goals of current research work in cellular immunology. The evidence presented in the current paper indicates that the allogeneic cells function by virtue of a specific immtmologic attack of grafted cells on host cells. This is concluded on the basis of the following evidence: L2C leukemia cells, which bear strain 2 histocompatibility antigens, 2 fail to prepare DNP-OVA-primed strain 13 recipients for a secondary anti-DNP response to DNP-BGG; similarly, irradiated strain 2 lymph node and spleen cells are without effect. In both instances, the transferred cells, although lacking the ability to mediate graft-versus-host responses, are capable of initiating a host-versus-graft response. The failure of these cells to mediate the allogeneic effect therefore indicates that the rejection of donor cells by the host is not the crucial event. Indeed, if the host is presensitized to donor transplantation antigens, as in the transfer of strain 2 cells into a DNP-OVA-primed strain 13 recipient which has been preimmunized with the L~C leukemia, the allogeneic effect is completely abolished. On the other hand, the notion that a graft-versushost response, or one of its components, is involved is strongly supported by the failure of (2 X 13)F1 hybrid lymph node and spleen cells to mediate the allogeneic effect in DNP-OVA-primed strain 13 recipients. These cells are normal immunocompetent cells but lack the capacity to recognize strain 13 histocompatibility antigens as foreign by virtue of their genetic constitution. Further, supportive evidence that the allogeneic effect is related to a graftversus-host phenomenon is provided by the considerable superiority of lymph node-spleen cell mixtures over spleen cells in mediating the response. This indicates that lymph node cells are superior to spleen cells and is in accord with the demonstration by Cantor, Mandel, and Asofsky (23) that, in the mouse, fewer lymph node cells than spleen cells are required to obtain a given spleen index in the Simonsen assay of the graft-versus-host reaction.
Howard and Woodruff (24) have shown that in adult immunocompetent mice undergoing a graft-versus-host response, primary antibody responses to the H antigen of Salmonella typhi were less than normal. They examined the response 14-19 days after cell transfer. In our studies, there was a striking difference in the outcome of antigenic challenge as the temporal relation between challenge and allogeneic cell transfer was varied. Thus, when challenge was carried out 13 days after transfer, no effect was noted; challenge at 6 days led to a marked augmentation, whereas challenge 1 or 3 days after transfer resulted in a depression of anti-DNP antibody concentrations as compared to nonchallenged recipients. This time dependence suggests that a precise relation exists between attack of transferred cells on host cells and antigenic stimulation of such cells. When antigenic challenge is administered 1 day after allogeneic cell transfer, the serum anti-DNP antibody concentrations are markedly depressed when compared with those of a nonchallenged animal. This may be the consequence either of transferred antigen binding synthesized antibody and causing its clearance, or alternatively it may represent a change in the state of differentiation of precursors of antibody-forming cells. That is, an initial interaction of DNP-BGG, for which very few helpers would be present, with precursors of anti-DNP antibody-synthesizing cells may render the cells insensitive to the subsequent stilnulatory effect of allogeneic cells.
The effectiveness of antigenic challenge 6 days after cell transfer, which is at a time when the graft-versus-host reaction or its immediate consequences might be quite intense, would suggest that the stimulation either of helper cells or of precursors of antibody-producing cells by antigen is markedly enhanced directly or by the release of adjuvant factors as a result of the immunologic attack of graft cells. The data described thus far do not allow a decision as to which of these two cell classes constitutes the relevant target cell for the expression of the allogeneic effect nor as to the mechanism of the effect. Further, an evaluation must still be made of what the nature of the effector allogeneic cell is. Cantor and Asofsky (25) have recently demonstrated a cooperative lymphoid cell interaction in graft-versus-host reactions in mice. They propose an interaction between two thymus-derived lymphocytes in which one cell initially encounters antigen and the second cell is responsible for the pathogenic aspects of the phenomenon. Which of these two cell types is effective in the allogeneic effect under study here is not known. Antibody-secreting cells of the donor are, however, unlikely to be important participants in this phenomenon. Thus, anti-BGG antibody, which is being produced by the transferred cells when they are placed in a syngeneic host, cannot be detected in the allogeneic recipient. This finding would be expected on the basis of the studies of ~terzl and Trnka (26) who demonstrated that antibody-producing cells are eliminated quite rapidly after transfer to immunocompetent allogeneic or xenogeneic hosts. It seems likely that the activation of the precursors of antibody-forming cells, particularly when no exogenous secondary antigenic challenge is administered, proceeds by a mechanism akin to the proliferation of host bone marrow-derived cells which is largely responsible for the splenomegaly observed in the graft-~Jersus-host response. Whether the effect of DNP-BGG in this case is directly upon DNP-specific precursors of antibody-forming cells or on helper cells has not been established. It is nevertheless tempting to consider that precursors of antibody-forming cells which are already receiving one type of stimulus (i.e. that resulting, directly or indirectly, from the attack of allogeneic cells) might be especially sensitive to antigenic stimulus. Under these circumitances, an initial interaction of antigen with carrier specific helper cells might be unnecessary. In turn, an evaluation of the details of this phenomenon may well provide insight into ~he normal stimuli which activate precursors of antibody-forming cells.
SUMMARY
The studies reported here demonstrate that immunocompetent lymphoid cells from allogeneic donor guinea pigs stimulate the synthesis of anti-DNP and anti-OVA antibodies by recipients previously primed with DNP-OVA. This allogeneic effect occurs spontaneously in the absence of any further antigenic challenge. Furthermore, the transfer of allogeneic cells prepares DNP-OVA-primed recipients for a striking secondary anti-DNP response to DNP-BGG; this occurs in equal degree whether or not the cells are derived from BGG-primed donors. We suggest that the allogeneic cells function by virtue of a specific immunologic attack of grafted cells on host cells. This conclusion is made on the basis of the following evidence: (a) The failure of observing the phenomenon with L2C leukemia cells and irradiated strain 2 lymph node and spleen cells which, although capable of initiating a host-versus-graft response, are incapable of mediating graft-versus-host reactions; and (b) the inability of (strain 2 X strain 13)F1 hybrids to mediate the allogeneic effect in strain 13 recipients. The analysis of this phenomenon may offer a key to the delineation of mechanisms involved in the activation of precursors of antibody-forming cells.
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